Zacks.com on MSN
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, ...
Zacks.com on MSN
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Penumbra, Inc.’s PEN robust product portfolio expansion is poised to drive growth in the upcoming quarters. Additionally, the ...
Get the latest U.S. stock market and healthcare sector updates, key company news, and top healthcare winners and losers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback